Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

FPHAX Fidelity® Select Pharmaceuticals Port

  • Fund
  • FPHAX
  • Price as of: Jul 09, 2019
  • $21.16 + $0.12 + 0.57%
  • Category
  • Health & Biotech Equities

FPHAX - Profile

Vitals

  • YTD Return 9.9%
  • 3 Yr Annualized Return 2.9%
  • 5 Yr Annualized Return 0.3%
  • Net Assets $721 M
  • Holdings in Top 10 67.6%

52 WEEK LOW AND HIGH

$21.16
$18.19
$21.65

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.80%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 55.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$0

IRA

$2,500

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 9.9%
  • 3 Yr Annualized Total Return 4.0%
  • 5 Yr Annualized Total Return 4.5%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.48%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Fidelity® Select Pharmaceuticals Portfolio
  • Fund Family Name Fidelity Investments
  • Inception Date Jun 18, 2001
  • Shares Outstanding N/A
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Karim Suwwan de Felipe

Fund Description

The Fidelity Select Pharmaceuticals Portfolio (FPHAX) is an actively managed fund that focuses on the health care sector. FPHAX hones in on those firms that research and develop drugs, including traditional pharmaceutical firms and biotech drug makers. The fund can hold domestic or foreign stocks of any size. FPHAX’s managers focus on innovation as well as profits when selecting the fund’s underlying portfolio.

Despite its low costs, FPHAX’s extremely narrow focus places it in the satellite position camp within a broader equity portfolio. The fund is run by several Fidelity offices.

FPHAX - Performance

Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.9% -3.0% 33.2% 56.86%
1 Yr 8.1% -24.9% 12.0% 1.96%
3 Yr 2.9%* -17.8% 22.2% 47.06%
5 Yr 0.3%* -11.9% 16.9% 58.16%
10 Yr 9.4%* -1.8% 16.1% 51.85%

* Annualized


Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2018 3.8% -25.3% 7.7% 2.94%
2017 8.9% -10.8% 43.9% 80.39%
2016 -17.2% -29.8% 2.6% 62.75%
2015 -3.8% -20.4% 13.8% 61.76%
2014 11.3% -5.8% 31.5% 67.35%

Total Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.9% -3.0% 33.2% 56.86%
1 Yr 8.1% -24.9% 12.0% 1.96%
3 Yr 4.0%* -17.8% 25.3% 64.71%
5 Yr 4.5%* -11.9% 18.8% 56.12%
10 Yr 14.7%* -1.8% 19.4% 32.10%

* Annualized


Total Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2018 4.4% -25.3% 12.3% 2.94%
2017 10.7% -10.8% 45.8% 88.24%
2016 -16.3% -24.2% 8.7% 72.55%
2015 8.3% -16.6% 15.2% 25.49%
2014 24.6% -5.8% 36.7% 48.98%

NAV & Total Return History

FPHAX - Holdings

Concentration Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Assets 721 M 13.9 M 44.3 B 73.53%
Number of Holdings 61 28 364 80.39%
Net Assets in Top 10 451 M 7.98 M 18.8 B 58.82%
Weighting of Top 10 67.63% 24.8% 75.2% 1.96%

Top 10 Holdings

  1. AstraZeneca PLC ADR 12.54%

  2. Johnson & Johnson 8.35%

  3. Roche Holding AG Dividend Right Cert. 8.29%

  4. Sanofi SA ADR 7.59%

  5. Bristol-Myers Squibb Company 7.26%

  6. Merck & Co Inc 5.92%

  7. Novartis AG ADR 4.99%

  8. Eli Lilly and Co 4.48%

  9. Allergan PLC 4.25%

  10. Zoetis Inc Class A 3.95%


Asset Allocation

Weighting Return Low Return High FPHAX % Rank
Stocks
99.48% 91.85% 103.82% 14.71%
Cash
0.52% 0.00% 5.75% 90.20%
Preferred Stocks
0.00% 0.00% 2.32% 44.12%
Other
0.00% -3.83% 2.75% 52.94%
Convertible Bonds
0.00% 0.00% 0.12% 32.35%
Bonds
0.00% 0.00% 0.94% 35.29%

Stock Sector Breakdown

Weighting Return Low Return High FPHAX % Rank
Healthcare
99.42% 13.80% 99.56% 4.90%
Utilities
0.00% 0.00% 0.00% 30.39%
Technology
0.00% 0.00% 61.10% 79.41%
Real Estate
0.00% 0.00% 1.36% 39.22%
Industrials
0.00% 0.00% 10.61% 53.92%
Financial Services
0.00% 0.00% 3.95% 44.12%
Energy
0.00% 0.00% 0.09% 32.35%
Communication Services
0.00% 0.00% 0.00% 30.39%
Consumer Defense
0.00% 0.00% 0.40% 38.24%
Consumer Cyclical
0.00% 0.00% 7.87% 45.10%
Basic Materials
0.00% 0.00% 0.79% 45.10%

Stock Geographic Breakdown

Weighting Return Low Return High FPHAX % Rank
US
60.46% 60.46% 99.56% 100.00%
Non US
39.02% 0.00% 39.02% 0.98%

FPHAX - Expenses

Operational Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.80% 0.10% 2.98% 87.25%
Management Fee 0.54% 0.09% 1.25% 6.86%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 0.75% 0.75% 2.00% 75.00%

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 55.00% 0.00% 699.00% 81.37%

FPHAX - Distributions

Dividend Yield Analysis

FPHAX Category Low Category High FPHAX % Rank
Dividend Yield 0.00% 0.00% 0.01% 42.16%

Dividend Distribution Analysis

FPHAX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Income Ratio 1.48% -2.15% 1.48% 0.98%

Capital Gain Distribution Analysis

FPHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

FPHAX - Managers

Karim Suwwan de Felipe

Manager

Start Date

Tenure

Tenure Rank

Jul 01, 2017

2.0

2.0%

Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager.


Tenure Analysis

Category Low

4.38

Category High

13.75

Category Average

9.07

Category Mode

4.38